Assessing angiotensin-converting enzyme (ACE) protein is more appropriate than ACE activity when investigating sarcoidosis

Med J Aust. 2020 Aug;213(4):178-179. doi: 10.5694/mja2.50620. Epub 2020 May 22.
No abstract available

Keywords: Antihypertensive agents; Autoimmune diseases; Biomarkers; Sarcoidosis.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / blood*
  • Sarcoidosis / drug therapy*
  • Sarcoidosis / enzymology*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • ACE protein, human
  • Peptidyl-Dipeptidase A